232 related articles for article (PubMed ID: 25935648)
1. Allosteric inhibition of factor XIa. Sulfated non-saccharide glycosaminoglycan mimetics as promising anticoagulants.
Al-Horani RA; Gailani D; Desai UR
Thromb Res; 2015 Aug; 136(2):379-87. PubMed ID: 25935648
[TBL] [Abstract][Full Text] [Related]
2. Designing allosteric inhibitors of factor XIa. Lessons from the interactions of sulfated pentagalloylglucopyranosides.
Al-Horani RA; Desai UR
J Med Chem; 2014 Jun; 57(11):4805-18. PubMed ID: 24844380
[TBL] [Abstract][Full Text] [Related]
3. Sulfated pentagalloylglucoside is a potent, allosteric, and selective inhibitor of factor XIa.
Al-Horani RA; Ponnusamy P; Mehta AY; Gailani D; Desai UR
J Med Chem; 2013 Feb; 56(3):867-78. PubMed ID: 23316863
[TBL] [Abstract][Full Text] [Related]
4. Medically-induced hemophilia C to treat thrombosis.
Schmaier AH
Thromb Res; 2015 Aug; 136(2):185-6. PubMed ID: 26024825
[No Abstract] [Full Text] [Related]
5. Allosteric inhibition of human factor XIa: discovery of monosulfated benzofurans as a class of promising inhibitors.
Argade MD; Mehta AY; Sarkar A; Desai UR
J Med Chem; 2014 Apr; 57(8):3559-69. PubMed ID: 24666186
[TBL] [Abstract][Full Text] [Related]
6. Discovery of Benzyl Tetraphosphonate Derivative as Inhibitor of Human Factor Xia.
Kar S; Mottamal M; Al-Horani RA
ChemistryOpen; 2020 Nov; 9(11):1161-1172. PubMed ID: 33204588
[TBL] [Abstract][Full Text] [Related]
7. Sulfonated non-saccharide molecules and human factor XIa: Enzyme inhibition and computational studies.
Al-Horani RA; Parsaeian E; Mohammad M; Mottamal M
Chem Biol Drug Des; 2022 Jul; 100(1):64-79. PubMed ID: 35377529
[TBL] [Abstract][Full Text] [Related]
8. A synthetic heparin mimetic that allosterically inhibits factor XIa and reduces thrombosis in vivo without enhanced risk of bleeding.
Al-Horani RA; Abdelfadiel EI; Afosah DK; Morla S; Sistla JC; Mohammed B; Martin EJ; Sakagami M; Brophy DF; Desai UR
J Thromb Haemost; 2019 Dec; 17(12):2110-2122. PubMed ID: 31397071
[TBL] [Abstract][Full Text] [Related]
9. Factor XIa inhibitors: A review of the patent literature.
Al-Horani RA; Desai UR
Expert Opin Ther Pat; 2016; 26(3):323-45. PubMed ID: 26881476
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the anticoagulant activity of cyclic sulfated glycosaminoglycan mimetics.
Chiles R; Afosah DK; Al-Horani RA
Carbohydr Res; 2023 Jul; 529():108831. PubMed ID: 37209666
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a heparin binding site on the heavy chain of factor XI.
Zhao M; Abdel-Razek T; Sun MF; Gailani D
J Biol Chem; 1998 Nov; 273(47):31153-9. PubMed ID: 9813019
[TBL] [Abstract][Full Text] [Related]
12. Lignosulfonic Acid Sodium Is a Noncompetitive Inhibitor of Human Factor XIa.
Kar S; Bankston P; Afosah DK; Al-Horani RA
Pharmaceuticals (Basel); 2021 Aug; 14(9):. PubMed ID: 34577586
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and biological evaluation of peptidomimetic inhibitors of factor XIa as novel anticoagulants.
Lin J; Deng H; Jin L; Pandey P; Quinn J; Cantin S; Rynkiewicz MJ; Gorga JC; Bibbins F; Celatka CA; Nagafuji P; Bannister TD; Meyers HV; Babine RE; Hayward NJ; Weaver D; Benjamin H; Stassen F; Abdel-Meguid SS; Strickler JE
J Med Chem; 2006 Dec; 49(26):7781-91. PubMed ID: 17181160
[TBL] [Abstract][Full Text] [Related]
14. Influence of low molecular weight heparin and low molecular weight dextran sulfate on the inhibition of coagulation factor XIa by serpins.
Mauron T; Lämmle B; Wuillemin WA
Thromb Haemost; 1998 Jul; 80(1):82-6. PubMed ID: 9684790
[TBL] [Abstract][Full Text] [Related]
15. Fragment-Based Lead Generation of 5-Phenyl-1
Wei Q; Zheng Z; Zhang S; Zheng X; Meng F; Yuan J; Xu Y; Huang C
Molecules; 2018 Aug; 23(8):. PubMed ID: 30103465
[TBL] [Abstract][Full Text] [Related]
16. Modulation of contact system proteases by glycosaminoglycans. Selective enhancement of the inhibition of factor XIa.
Wuillemin WA; Eldering E; Citarella F; de Ruig CP; ten Cate H; Hack CE
J Biol Chem; 1996 May; 271(22):12913-8. PubMed ID: 8662679
[TBL] [Abstract][Full Text] [Related]
17. Discovery of allosteric modulators of factor XIa by targeting hydrophobic domains adjacent to its heparin-binding site.
Karuturi R; Al-Horani RA; Mehta SC; Gailani D; Desai UR
J Med Chem; 2013 Mar; 56(6):2415-28. PubMed ID: 23451707
[TBL] [Abstract][Full Text] [Related]
18. Discovery of Chromen-7-yl Furan-2-Carboxylate as a Potent and Selective Factor XIa Inhibitor.
Obaidullah AJ; Al-Horani RA
Cardiovasc Hematol Agents Med Chem; 2017 Nov; 15(1):40-48. PubMed ID: 28552062
[TBL] [Abstract][Full Text] [Related]
19. Studies on fragment-based design of allosteric inhibitors of human factor XIa.
Boothello RS; Sankaranarayanan NV; Afosah DK; Karuturi R; Al-Horani RA; Desai UR
Bioorg Med Chem; 2020 Dec; 28(23):115762. PubMed ID: 32992249
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a heparin-binding site on the catalytic domain of factor XIa: mechanism of heparin acceleration of factor XIa inhibition by the serpins antithrombin and C1-inhibitor.
Yang L; Sun MF; Gailani D; Rezaie AR
Biochemistry; 2009 Feb; 48(7):1517-24. PubMed ID: 19178150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
